GlassScriptPhysician profile
James A Mann
NPI 1639581473
$24,572.79
in general payments reported to CMS, 2019-2025
16 companies · $4,366 in 2025
The $4,366 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.94 · 2020: $6,384 · 2021: $6,476 · 2022: $3,471 · 2023: $2,124 · 2024: $1,714 · 2025: $4,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,161 · Travel and Lodging: $4,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,160.77 |
| Travel and Lodging | $4,042.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,709.16 | 2020-2025 | Watchman Access System, Emblem Mri S-Icd, Watchman |
| Abbott Laboratories | $5,655.47 | 2019-2025 | Aveir, Ensite Precision, Agilis |
| Medtronic, INC. | $5,475.11 | 2021-2025 | Evera Mri Xt Dr Surescan, Selectsecure, Aurora Ev-Icd Mri Surescan |
| Biotronik INC. | $1,575.81 | 2025 | Acticor 7 Vr-T Dx |
| Biosense Webster, INC. | $803.50 | 2020-2025 | Carto 3 |
| Cardiva Medical, INC. | $111.73 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.19 | 2023 | Lifevest |
| Kestra Medical Technology Services, INC. | $46.90 | 2024-2025 | Assure Wcd |
| Atricure, INC. | $28.59 | 2025 | Atriclip Laa Exclusion System |
| Kiniksa Pharmaceuticals International, Plc | $21.00 | 2024 | Arcalyst |
| Merck Sharp & Dohme LLC | $19.15 | 2023 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.28 | 2023 | Jardiance |
| Cook Medical LLC | $16.58 | 2024 | Zilver Ptx |
| Cordis US Corp. | $14.92 | 2024 | Mynx Control |
| Chiesi USA, INC. | $14.72 | 2023 | Kengreal |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.